Financial Reports Latest Updates Industry Maps Economic Calendar

CORCEPT THERAPEUTICS INC (CORT) Annual Reports

Q: Where can I read CORCEPT THERAPEUTICS INC (CORT) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

CORCEPT THERAPEUTICS INC is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1088856 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$256.1M	$194.4M	+31.7%
Operating income	$41.3M	$26.7M	+54.8%
Net income	$43.0M	$35.1M	+22.3%
EPS (diluted)	$0.36	$0.29	+24.1%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 256 mn Net income 43.0 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	0.03	—	—	—	—	1.01	0	0	0	0.88	1.06	1.38	1.72	1.89	2.63	4.12	4.41	5.85	7.28	9.01	10.1	12.0	13.3	15.0	16.1	19.7	21.7	23.8	27.6	35.6	42.8	53.3	57.7	62.3	64.4	66.8	64.8	72.3	81.5	87.9	93.3	88.6	86.3	85.7	79.4	91.6	96.1	98.8	93.7	103	102	103	106	118	124	135	147	164	183	182	157	194	208	202	165	256
Gross profit	—	—	—	—	—	—	—	—	—	0.83	1.03	1.36	1.70	1.87	2.59	4.06	4.23	5.64	7.05	8.76	9.80	11.5	13.0	14.6	15.7	19.3	21.1	23.3	26.9	34.8	41.8	52.1	56.5	61.2	63.1	65.3	63.6	70.9	80.0	86.5	91.4	87.3	85.1	84.5	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Operating income	-20.3	-6.44	-7.10	-7.82	-7.10	-8.87	-6.44	-9.93	-11.0	-7.59	-7.67	-9.98	-10.9	-10.8	-9.74	-10.0	-12.9	-6.58	-5.10	-3.08	-4.03	-1.17	0.1	1.65	0.59	1.51	3.07	5.01	4.74	12.8	13.6	21.7	21.0	20.6	23.0	24.9	19.0	24.6	33.0	35.0	37.7	35.3	24.7	30.5	19.6	31.9	36.2	36.7	26.8	31.4	31.9	22.5	14.8	29.6	31.2	31.7	29.5	35.6	46.6	25.3	3.42	26.7	10.2	4.49	-49.6	41.3
Net income	-20.2	-5.69	-7.10	-7.09	-7.10	-8.88	-6.43	-9.94	-11.0	-7.60	-8.29	-11.1	-12.1	-11.9	-10.9	-11.1	-13.9	-7.55	-6.01	-3.89	-4.83	-1.94	-0.6	0.96	-0.02	0.98	2.59	4.60	4.39	12.7	13.8	98.3	17.5	18.2	17.8	22.0	18.3	20.2	26.3	29.4	30.1	28.3	21.6	26.0	23.5	26.5	30.5	32.0	22.8	27.4	34.6	16.6	15.9	27.5	31.4	31.4	27.8	35.5	47.2	30.8	20.6	35.1	19.7	24.3	-31.8	43.0

Balance sheet

Quarterly · In mn (USD)

Total assets 889 mn Total liabilities 183 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	25.0	—	52.7	46.3	39.8	42.8	38.3	105	95.1	84.2	74.6	66.2	58.3	48.1	39.4	32.4	30.2	44.2	44.7	45.2	49.0	50.5	54.8	59.8	65.7	66.7	81.3	93.9	124	151	197	224	237	217	233	267	307	345	438	463	479	410	411	402	266	388	419	452	499	534	433	432	459	503	561	467	472	439	443	541	485	426	440
Total assets	—	—	—	25.1	—	52.7	46.4	39.8	42.9	38.6	106	99.2	88.1	79.7	71.1	63.1	52.8	44.4	37.2	34.6	48.2	48.4	48.4	51.9	52.9	56.8	62.9	68.8	75.3	86.5	111	221	243	274	300	312	320	329	367	412	445	498	534	572	552	568	585	424	468	496	533	583	618	525	594	622	656	715	784	841	846	802	824	837	815	889
Current liabilities	—	—	—	3.86	—	3.86	2.71	5.03	3.57	5.82	5.55	8.36	8.24	9.08	10.1	12.7	15.2	13.3	12.5	13.6	15.5	17.4	18.8	20.9	24.0	27.4	31.7	27.4	25.8	20.4	24.4	29.6	27.8	30.9	40.2	35.6	34.2	30.4	32.4	38.8	34.1	42.2	43.0	47.5	40.6	45.4	44.8	47.5	57.2	49.1	53.1	72.5	78.9	93.1	122	105	97.2	101	126	141	143	145	172	166	149	154
Total liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	29.6	—	—	—	35.8	34.5	30.6	32.6	41.1	36.0	44.1	44.5	48.4	41.6	45.8	45.2	48.0	60.3	54.0	59.9	81.6	88.3	103	132	115	108	118	145	161	163	166	192	189	177	183
Equity	22.1	—	—	21.2	—	48.9	43.7	34.8	39.3	32.8	71.7	61.8	51.0	40.4	30.8	21.0	9.37	3.45	-1.32	-3.39	10.6	11.5	13.5	18.5	20.2	25.7	31.3	41.4	49.6	66.2	86.3	191	215	244	260	276	286	298	334	371	409	454	490	523	511	523	540	376	408	442	473	502	530	422	462	507	548	596	639	680	683	636	632	648	638	706

Cash flow

Quarterly · In mn (USD)

Operating 33.5 mn Investing -29.2 mn Financing -2.04 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-18.0	-10.4	-6.43	-5.45	-7.29	-7.21	-6.60	-6.29	-10.2	-7.89	-9.23	-8.74	-11.6	-9.24	-8.60	-7.67	-11.1	-8.98	-5.93	-1.40	-1.78	-0.14	0.88	4.16	3.30	1.59	8.94	4.57	9.56	15.6	10.9	24.9	34.4	15.2	44.5	21.5	23.7	25.6	38.4	48.5	33.3	53.2	30.4	35.1	25.4	44.3	48.7	49.4	35.3	18.0	33.6	33.4	26.0	42.3	52.9	5.89	23.8	41.2	73.8	59.3	5.13	43.9	54.5	38.5	-16.8	33.5
Investing	3.59	—	—	—	—	-0.06	0	-0.02	-0.01	-0.03	-0.05	-0.06	-0.02	0	-0.06	-0.04	-0.11	-0.05	-0.02	0	-0.03	0	0	0.02	-0.02	-0.01	-0.09	-0.07	-19.4	-14.9	-11.7	-27.4	-34.3	-21.2	-33.5	-1.76	-0.37	-1.16	-54.3	-62.0	19.7	-85.9	-64.3	11.2	-3.28	24.7	-25.8	140	-50.5	-41.8	-4.79	-17.2	207	-24.1	-110	17.1	-9.01	-60.2	-44.0	-64.4	-3.17	70.1	14.7	-11.8	4.54	-29.2
Financing	23.5	21.9	0.02	1.06	41.9	0.24	0.28	0.05	13.2	0.2	76.0	0.2	—	—	-0.38	-0.59	-0.09	-0.61	-1.25	-1.13	15.5	-0.77	-1.48	-0.19	-2.97	-0.54	-2.77	-0.82	-3.71	-4.97	-1.84	2.57	1.92	4.04	-8.27	-12.0	-15.3	-15.9	2.70	-0.14	0.21	6.80	5.87	-0.66	-46.0	-26.0	-23.6	-207	-0.51	-2.76	-14.0	-0.06	0.18	-146	-3.92	0.77	-0.54	-2.15	-21.1	-4.56	-39.8	-103	-46.4	-31.2	0.76	-2.04
Cash at period end	23.9	35.4	29.0	24.6	59.2	52.2	45.9	39.6	42.6	34.9	102	93.0	81.5	72.2	63.2	54.9	43.6	34.0	26.8	24.3	38.0	37.0	36.5	40.4	40.7	41.8	47.9	51.5	38.0	33.6	31.1	31.1	33.1	31.2	33.9	41.6	49.6	58.1	45.0	31.3	84.5	58.5	30.6	76.2	52.4	95.4	94.7	77.6	61.9	35.4	50.2	66.3	300	172	112	136	150	129	137	128	89.8	103	125	121	109	111

Profitability

Quarterly · %

Gross margin 98.5% Operating margin 16.1% Net margin 16.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	—	—	—	—	—	94.5%	97.7%	98.6%	98.8%	98.8%	98.5%	98.5%	96.0%	96.3%	96.8%	97.1%	97.0%	96.3%	98.1%	97.6%	97.5%	97.8%	96.9%	97.6%	97.7%	97.8%	97.7%	97.8%	98.0%	98.2%	98.0%	97.6%	98.1%	98.1%	98.2%	98.4%	98.0%	98.6%	98.6%	98.5%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Operating margin	-69827.6%	—	—	—	—	-874.6%	—	—	—	-867.7%	-727.1%	-724.8%	-637.3%	-570.2%	-369.8%	-243.7%	-291.9%	-112.5%	-70.1%	-34.1%	-39.9%	-9.8%	0.8%	11.0%	3.7%	7.7%	14.1%	21.0%	17.2%	36.0%	31.9%	40.7%	36.4%	33.1%	35.6%	37.3%	29.2%	34.1%	40.5%	39.8%	40.4%	39.8%	28.6%	35.6%	24.7%	34.9%	37.7%	37.1%	28.6%	30.4%	31.4%	21.8%	14.1%	25.1%	25.2%	23.4%	20.1%	21.7%	25.5%	13.9%	2.2%	13.7%	4.9%	2.2%	-30.1%	16.1%
Net margin	-69537.9%	—	—	—	—	-875.9%	—	—	—	-868.2%	-786.1%	-807.8%	-703.8%	-629.1%	-414.1%	-270.3%	-316.2%	-129.1%	-82.5%	-43.2%	-47.8%	-16.2%	-4.5%	6.4%	-0.1%	5.0%	11.9%	19.3%	15.9%	35.6%	32.2%	184.6%	30.3%	29.2%	27.5%	32.9%	28.2%	27.9%	32.3%	33.4%	32.2%	32.0%	25.1%	30.3%	29.5%	29.0%	31.7%	32.4%	24.3%	26.5%	34.0%	16.1%	15.0%	23.4%	25.4%	23.2%	18.9%	21.7%	25.9%	16.9%	13.1%	18.1%	9.5%	12.0%	-19.3%	16.8%

Returns & leverage

Quarterly · %

ROE 8.2% ROA 6.5% Debt ratio 20.6%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	-188.6%	—	-61.8%	-67.6%	-115.4%	-92.3%	-85.7%	-63.9%	-78.8%	-86.6%	-118.6%	-89.8%	-111.2%	-158.5%	-198.6%	-262.2%	-356.0%	-223.5%	-222.6%	-185.2%	-84.8%	-10.4%	7.1%	20.1%	27.2%	36.0%	52.8%	60.2%	111.2%	107.4%	95.4%	87.8%	32.3%	30.4%	28.9%	29.2%	29.1%	30.5%	30.4%	26.6%	23.7%	21.6%	20.0%	20.7%	25.0%	24.4%	23.4%	23.1%	23.1%	20.2%	21.9%	19.6%	21.1%	21.9%	24.8%	25.8%	23.8%	21.8%	21.7%	16.7%	15.0%	7.2%	8.2%
ROA	—	—	—	-159.6%	—	-57.3%	-63.6%	-99.7%	-84.6%	-76.6%	-48.5%	-54.8%	-59.7%	-73.4%	-52.1%	-56.7%	-67.9%	-70.1%	-71.4%	-64.2%	-44.1%	-35.9%	-26.3%	-14.8%	-3.2%	2.5%	8.1%	13.5%	19.6%	33.8%	40.8%	89.3%	89.3%	81.9%	73.9%	28.3%	27.1%	25.9%	26.0%	26.0%	27.7%	27.6%	24.3%	21.6%	19.9%	18.3%	19.0%	22.6%	21.9%	21.2%	20.9%	20.1%	17.4%	18.5%	16.2%	17.6%	18.5%	20.3%	20.6%	19.3%	17.8%	17.6%	13.2%	11.9%	5.7%	6.5%
Debt ratio	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	13.4%	—	—	—	11.5%	10.8%	9.3%	8.9%	10.0%	8.1%	8.9%	8.3%	8.5%	7.5%	8.1%	7.7%	11.3%	12.9%	10.9%	11.2%	14.0%	14.3%	19.6%	22.3%	18.5%	16.5%	16.6%	18.5%	19.1%	19.3%	20.7%	23.3%	22.6%	21.7%	20.6%

EPS

Quarterly · US$

EPS US$0.36

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q3	2011Q4	2011Q4	2011Q4	2012Q4	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.06	—	0.01	0.02	0.04	0.04	0.10	0.11	0.77	0.14	0.14	0.14	0.18	0.15	0.17	0.22	0.24	0.25	0.23	0.17	0.20	0.18	0.21	0.24	0.26	0.20	0.24	0.30	0.14	0.14	0.25	0.28	0.28	0.25	0.32	0.41	0.25	0.17	0.29	0.16	0.20	-0.30	0.36

Revenue & profit

Year-to-date · In mn (USD)

Revenue 421 mn Net income 11.2 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 889 mn Total liabilities 183 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 16.8 mn Investing -24.7 mn Financing -1.28 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 98.4% Operating margin -2.0% Net margin 2.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 8.2% ROA 6.5% Debt ratio 20.6%

EPS

Year-to-date · US$

EPS US$0.06

Revenue & profit

Annual · In mn (USD)

Revenue 761 mn Net income 99.7 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	10.4	26.6	50.3	81.3	159	251	306	354	366	402	482	675	761
Gross profit	10.2	25.7	48.9	79.3	156	246	301	348	—	—	—	—	—
Operating income	-41.5	-27.6	-3.44	10.2	52.9	89.5	112	128	124	113	107	137	44.8
Net income	-46.0	-31.4	-6.41	8.14	129	75.4	94.2	106	113	101	106	141	99.7

Balance sheet

Annual · In mn (USD)

Total assets 837 mn Total liabilities 189 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	58.3	30.2	49.0	65.7	124	237	307	479	266	499	459	472	485
Total assets	63.1	34.6	51.9	68.8	221	312	412	572	424	583	622	841	837
Current liabilities	12.7	13.6	20.9	27.4	29.6	35.6	38.8	47.5	47.5	72.5	105	141	166
Total liabilities	—	—	—	—	29.6	35.8	41.1	48.4	48.0	81.6	115	161	189
Equity	21.0	-3.39	18.5	41.4	191	276	371	523	376	502	507	680	648

Cash flow

Annual · In mn (USD)

Operating 142 mn Investing 69.8 mn Financing -220 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-37.1	-27.4	3.13	18.4	60.9	116	136	152	168	120	127	198	142
Investing	-0.13	-0.17	-0.02	-0.19	-73.5	-90.8	-118	-119	136	-114	90.9	-178	69.8
Financing	—	-3.08	13.1	-7.10	-7.95	-14.3	-28.6	12.2	-303	-17.3	-149	-28.4	-220
Cash at period end	54.9	24.3	40.4	51.5	31.1	41.6	31.3	76.2	77.6	66.3	136	128	121

Profitability

Annual · %

Gross margin 98.4% Operating margin 5.9% Net margin 13.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	98.6%	96.7%	97.3%	97.5%	97.8%	97.9%	98.2%	98.4%	—	—	—	—	—
Operating margin	-400.7%	-104.0%	-6.8%	12.5%	33.2%	35.6%	36.4%	36.2%	34.0%	28.0%	22.2%	20.3%	5.9%
Net margin	-444.3%	-118.2%	-12.7%	10.0%	81.1%	30.0%	30.7%	30.0%	30.7%	25.2%	22.0%	20.9%	13.1%

Returns & leverage

Annual · %

ROE 15.0% ROA 11.9% Debt ratio 22.6%

Show table：Returns & leverage

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-218.9%	-356.0%	-84.8%	27.2%	111.2%	32.3%	29.1%	23.7%	25.0%	23.1%	21.1%	23.8%	15.0%
ROA	-72.9%	-64.2%	-14.8%	13.5%	89.3%	28.3%	26.0%	21.6%	22.6%	20.1%	17.6%	19.3%	11.9%
Debt ratio	—	—	—	—	13.4%	11.5%	10.0%	8.5%	11.3%	14.0%	18.5%	19.1%	22.6%

EPS

Annual · US$

EPS US$0.82

Show table：EPS

Item	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	1.02	0.60	0.78	0.85	0.89	0.88	0.95	1.23	0.82

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read CORCEPT THERAPEUTICS INC (CORT) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.